Background & Aims The guidelines of the European Society of Pediatric Gastroenterology,
Hepatology, and Nutrition allow for diagnosis of celiac disease without biopsies in children …

We aimed to evaluate the prognostic significance of traditional clinical predictors in osteosarcoma
through an international collaboration of 10 teams of investigators (2680 patients) who …

The known effects of a novel stomach pentadecapeptide BPC157 (10 μg or 10 ng/kg),
namely its salutary activity against ethanol (96%, ig)-induced gastric lesions (simultaneously …

This review focuses on the described effects of BPC 157 on blood vessels after different types
of damage, and elucidate by investigating different aspects of vascular response to injury (…

The 15 amino acid agent BPC 157, showing a wide range of organoprotective action in different
experimental models, was used in our experiments in order to establish its influence on …

The protection of stomach and duodenum in conjecture with anti-inflammatory effect was
demonstrated for a novel 15 amino acid peptide, coded BPC 157, a fragment of the recently …

We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close
participation in Moncada's (maintained vascular integrity, platelets control) homeostatic healing …

Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in
clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and …

Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in inflammatory
bowel disease clinical trials (GEPPPGKPADDAGLV, MW 1419, PL 14736) and wound …

Overall, doxorubicine-congestive heart failure (CHF)(male Wistar rats and NMRI mice; 6
challenges with doxorubicine (2.5 mg/kg, ip) throughout 15 days and then a 4-weekrest period) …